Man-made antibody successfully prevents organ rejection after transplantation

FHS
August 30, 2023
10:10 pm

A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.

Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase

March 21, 2024

Mayo Clinic, Terasaki Institute announce research collaboration for improving organ transplant outcomes

Mayo Clinic and Terasaki Institute for Biomedical Innovation announced today a research collaboration centered on improving organ transplant outcomes.

April 5, 2024

Experts Lament ‘Anemic’ Response to H5N1, Worried About What 2025 Will Bring

This year, human cases of H5N1 bird flu ramped up in the U.S., particularly after the virus made its way into dairy cattle herds. In

December 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.